# Arima Genomics

> Arima Genomics is a Carlsbad, California biotech commercializing Hi-C technology - sequencing methods that reveal the 3D structure of the genome. Its research kits help scientists assemble chromosome-scale genomes and study chromatin architecture, while its clinical brand Aventa Genomics turns the same proximity-ligation chemistry into FFPE-friendly cancer tests for fusions, rearrangements, and other structural variants conventional NGS often misses.

- **Founded:** 2015
- **Headquarters:** Carlsbad, California, United States
- **Founders:** Siddarth Selvaraj (Co-founder, President & COO (former CEO)), William Alaynick (Co-founder)
- **Team size:** ~46
- **Products:** Arima-HiC+ Kit, Genome-Wide HiC, Capture HiC, Genome Assembly Application, Aventa FusionPlus
- **Notable:** Reduced Hi-C sample prep from ~2 days to ~6 hours., Selected by Wellcome Sanger Institute as Hi-C technology partner., Launched Aventa Genomics CLIA clinical lab via joint venture (2023).

## Products & services

- **Arima-HiC+ Kit** — Six-hour proximity-ligation sample preparation kit that captures genome-wide chromatin interactions for downstream NGS.
- **Genome-Wide HiC** — End-to-end assay for studying 3D genome organization, gene regulation, and structural variation.
- **Capture HiC** — Targeted enrichment of regions of interest for higher-resolution chromatin interaction mapping (e.g., promoter capture).
- **Genome Assembly Application** — Long-range Hi-C reads used to scaffold contigs into chromosome-scale assemblies for de novo genome projects.
- **Aventa FusionPlus** — CLIA clinical test for solid tumors detecting gene fusions and structural rearrangements directly from FFPE samples.
- **Aventa Lymphoma** — Clinical assay supporting lymphoma classification and diagnosis using 3D genome signal.
- **Biopharma Services** — Custom Hi-C and structural-variant services for pharma R&D and translational research.

## Achievements

- Reduced Hi-C sample prep from ~2 days to ~6 hours.
- Selected by Wellcome Sanger Institute as Hi-C technology partner.
- Launched Aventa Genomics CLIA clinical lab via joint venture (2023).
- Closed $22M Series C in June 2025 led by Illumina Ventures.
- Hi-C data underpins many chromosome-scale reference genomes in public databases.

## Latest updates

- **2025-06** — Closed $22M Series C led by Illumina Ventures; Tom Willis named CEO, founder Sid Selvaraj transitions to President & COO.
- **2023** — Launched Aventa Genomics clinical lab joint venture with Protean BioDiagnostics.
- **2020-10** — Wellcome Sanger Institute selected Arima as Hi-C technology partner; high-coverage HiC early access launched.

## Links

- Website: https://arimagenomics.com
- LinkedIn: https://www.linkedin.com/company/arima-genomics-inc-
- Twitter/X: https://twitter.com/ArimaGenomics
- YouTube: https://www.youtube.com/@arimagenomics

---

Profile page: https://yespress.io/arima-genomics
Published by YesPress — https://yespress.io
Last updated: 2026-06-29